Press release
Biochip Products Market Share by U.S. Industry 2018
The development of biochips marks a crucial feat for the biotechnology industry. A biochip is essentially a collection of miniature test locations arranged on a solid substrate capable of undergoing many tests at the same time, leading to a higher throughput and quick examinations. Similar to a computer chip that can undertake millions of mathematical functions in the span of a second, a biochip can unravel the complex biochemical reactions occurring within cells, such as decoding genes, within seconds.As technological advancements in the field of biotechnology and the science of micro-miniaturization make possible increasingly powerful biochips, the demand for these “miniaturized laboratories” is rising from a variety of application areas. From being known as a highly reliable means of unraveling the complex biochemical reactions taking place inside cells to being able to gather vast data about human genomes, biochips are increasingly expanding their application across many industries.
According to a market research report by Transparency Market Research, the global biochip products and services market will exhibit a 10.1% CAGR over the period between 2012 and 2018 and rise to a valuation of US$4.7 bn by 2018.
Download Exclusive Global Strategic Business Report: http://bit.ly/2iX0rdh
Biochips are Increasingly Becoming One of the Drug Discovery Field’s Core Necessities
Although biochips are typically associated with DNA chips, which are biochips designed to screen biological samples for genetic information, they can also be applied in the investigation of a variety of other biological and biochemical elements. In this scenario, one of the most intriguing applications of biochips is that of screening of drugs. Biochips can be effectively utilized to examine the risks and benefits of pharmaceutical compounds.
Drug discovery is a highly complex and expensive process, with more than 99% of the investigated experimental compounds being discarded as failures in a vast number of research and development activities. It is common for drug companies to expect only a handful of the compounds examined as a part of clinical trials to actually make it to the marketplace. Clinical trials account for over 35% of the finances allocated to the entire R&D process, and the global pharmaceutical industry invests billions of dollars to this phase of drug discovery every year.
Biochips can Improve Throughput, Reduce Attrition Rates of Drugs
Over the years, biochips have become indispensable tools for the development of new drugs and improvement of existing ones. The improved bioinformatics techniques and high-volume screening allowed by today’s advanced biochips are leading to a dramatic rise in the sample outputs. This is helping in speeding drug discovery by cutting down the attrition rate of pharmaceutical compounds that do not pass clinical trials and reducing the drug pipeline timelines.
In the fiercely competitive pharmaceutical industry of current times, the provision of value-added services by the virtue of biochip products and services will prove to be highly critical for success in the near future. Thus, biochip products and services will find an increased demand in the field of drug discovery in the coming years.
Browse Full Research Report on Biochip Products and Services Market:
http://www.transparencymarketresearch.com/biochip-products-services.html
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biochip Products Market Share by U.S. Industry 2018 here
News-ID: 407147 • Views: …
More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…

North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…

Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016.
The global dental membrane and bone graft substitutes market is expected to…

Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period.
By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…
More Releases for Biochip
Biochip Market Size, Share, Growth & Industry Report Analysis 2032
Biochip Market Overview
The biochip market refers to the use of microchips that integrate biological molecules such as DNA, proteins, and enzymes for diagnostics, drug development, and genetic testing. These compact devices offer high-throughput screening and multiplexing capabilities, enabling advancements in personalized medicine and disease detection. With the rise in chronic diseases, such as cancer, diabetes, and cardiovascular diseases, biochips are becoming essential in early diagnosis, monitoring, and precision treatment. As…
Biochip Market Size, Share, Report and Forecast 2024-2032
The global biochip market size was valued at USD 6.7 billion in 2023, driven by the rising prevalence of chronic diseases, and increased preference for personalized medicine across the globe. The market is expected to grow at a CAGR of 14.36% during the forecast period of 2024-2032, with the values likely to rise from USD 14.2 billion in 2024 to USD 41.4 billion by 2032.
Biochip: Introduction
Biochips are miniature laboratories that…
Global Automatic Biochip Reader Market Research Report 2023-2029
Automatic Biochip Reader report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Automatic Biochip Reader market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Tumor Detection and Drug Screening are the major drivers for the industry.
Global Leading Market Research Publisher QYResearch announces…
Liquid Biochip Analyzer Market Analysis,Demand,Trends and Forecast 2029
Global Info Research announces the release of the report "Global Liquid Biochip Analyzer Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029" . The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets.…
Global Biochip Reader Market - Opportunities & Forecasts, 2020-2029
Dhirtek Business Research and Consulting recently released its most comprehensive research report to date on the global biochip reader market. Through extensive research, analysts have provided an extensive look into the market's drivers and restraints, and identified the key milestones and trends that will shape its future.
Primary and secondary research methods were used to create this in-depth report. Through the analysis of the research, Dhirtek was able to identify the…
Biochip Market 2022 | Detailed Report
The Biochip research report provides a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The data thus presented is reliable, comprehensive and the result of extensive research both primary and secondary. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. Moreover, the data underlines the primary and secondary drivers, market…